Evidence map›Paper›PMID 24777604›Full record

ArticleMolecular and cellular biology2014

Caveolin-1 regulates genomic action of the glucocorticoid receptor in neural stem cells.

Melanie E Peffer, Uma R Chandran, Soumya Luthra, Daniela Volonte, Ferruccio Galbiati, Michael J Garabedian, A Paula Monaghan, Donald B DeFranco

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Caveolin1: its roles in normal and cancer stem cells.Journal of cancer research and clinical oncology · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Glucocorticoid receptor isoform-specific regulation of development, circadian rhythm, and inflammation in mice.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Melanie E Peffer
Uma R Chandran
Soumya Luthra
Daniela Volonte
Ferruccio Galbiati
Michael J Garabedian
A Paula Monaghan
Donald B DeFranco
University of Pittsburgh · USNew York University · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jessie Nedrow · 1988 to 2026
$158.0M
University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
PREDOCTORAL TRAINING IN PHARMACOLOGICAL SCIENCEST32GM008424 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PAGANO, PATRICK J · 1994 to 2019
$3.4M
Mechanisms of BDNF and Glucocorticoid ActionR01MH086651 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CHAO, MOSES VICTOR, GARABEDIAN, MICHAEL J. · 2009 to 2013
$3.1M
Intracellular Mechanisms of Glucocorticoid ActionR01DK078394 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DEFRANCO, DONALD B · 2007 to 2011
$1.5M
Caveolin 1: a novel modulator of the PP2A/ATM/p53 pathwayR01AG030636 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GALBIATI, FERRUCCIO · 2009 to 2013
$1.5M
NCATS NIH HHS UL1 TR000005NCI NIH HHS P30 CA047904NCI NIH HHS P30CA047904NIA NIH HHS AG030636NIA NIH HHS R01 AG030636NIDDK NIH HHS DK078394NIDDK NIH HHS R01 DK078394NIGMS NIH HHS T32 GM008424NIGMS NIH HHS T32GM008424NIMH NIH HHS MH086651NIMH NIH HHS R01 MH086651
6 · The paper itself

Abstract

While glucocorticoids (GCs) are used clinically to treat many conditions, their neonatal and prenatal usage is increasingly controversial due to reports of delayed adverse outcomes, especially their effects on brain development. Such alterations may reflect the impact of GCs on neural progenitor/stem cell (NPSC) function. We previously demonstrated that the lipid raft protein caveolin-1 (Cav-1) was required for rapid GC signaling in embryonic mouse NPSCs operating through plasma membrane-bound glucocorticoid receptors (GRs). We show here that genomic GR signaling in NPSCs requires Cav-1. Loss of Cav-1 impacts the transcriptional response of many GR target genes (e.g., the serum- and glucocorticoid-regulated kinase 1 gene) that are likely to mediate the antiproliferative effects of GCs. Microarray analysis of wild-type C57 or Cav-1-deficient NPSCs identified approximately 100 genes that are differentially regulated by GC treatment. These changes in hormone responsiveness in Cav-1 knockout NPSCs are associated with the loss of GC-regulated phosphorylation of GR at serine 211 but not at serine 226. Chromatin recruitment of total GR to regulatory regions of target genes such as Fkbp-5, RhoJ, and Sgk-1, as well as p211-GR recruitment to Sgk-1, are compromised in Cav-1 knockout NPSCs. Cav-1 is therefore a multifunctional regulator of GR in NPSCs influencing both rapid and genomic action of the receptor to impact cell proliferation.

Indexed as

Regulatory Elements, TranscriptionalAnimalsBase SequenceCaveolin 1Cell ProliferationChromatinDexamethasoneEmbryo, MammalianGene Expression RegulationGene Knockout TechniquesGlucocorticoidsMiceMice, Inbred C57BLMolecular Sequence DataNeural Stem CellsOligonucleotide Array Sequence AnalysisCaveolin 1ChromatinDexamethasoneGlucocorticoidsReceptors, GlucocorticoidSerine

Identifiers

PMID24777604
PMCPMC4097667
OpenAlexW2127535778

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.